Karen Herd

700 total citations
24 papers, 573 citations indexed

About

Karen Herd is a scholar working on Immunology, Epidemiology and Molecular Biology. According to data from OpenAlex, Karen Herd has authored 24 papers receiving a total of 573 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 17 papers in Epidemiology and 6 papers in Molecular Biology. Recurrent topics in Karen Herd's work include Immunotherapy and Immune Responses (15 papers), Cervical Cancer and HPV Research (9 papers) and Hepatitis B Virus Studies (6 papers). Karen Herd is often cited by papers focused on Immunotherapy and Immune Responses (15 papers), Cervical Cancer and HPV Research (9 papers) and Hepatitis B Virus Studies (6 papers). Karen Herd collaborates with scholars based in Australia, United States and United Kingdom. Karen Herd's co-authors include Robert W. Tindle, Tracy Doan, Germain J. P. Fernando, Michael Street, Paul F. Lambert, Ian H. Frazer, Suresh Mahalingam, Gordon Dougan, Theo P. Sloots and Michael D. Nissen and has published in prestigious journals such as Journal of Virology, American Journal of Public Health and The Journal of Infectious Diseases.

In The Last Decade

Karen Herd

23 papers receiving 560 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karen Herd Australia 15 387 321 127 126 69 24 573
Petra Riedl Germany 15 378 1.0× 250 0.8× 231 1.8× 101 0.8× 84 1.2× 32 617
Marloes L. H. De Bruijn Netherlands 10 632 1.6× 282 0.9× 174 1.4× 38 0.3× 95 1.4× 12 809
Marie-Louise Michel France 8 361 0.9× 287 0.9× 245 1.9× 131 1.0× 90 1.3× 12 678
Sabine Pingel Germany 13 278 0.7× 378 1.2× 112 0.9× 73 0.6× 32 0.5× 23 756
Kenichiro Murata Japan 8 414 1.1× 238 0.7× 192 1.5× 99 0.8× 85 1.2× 19 722
Lauren E. Grandpre United States 11 658 1.7× 296 0.9× 303 2.4× 281 2.2× 146 2.1× 13 1.2k
Sherry R. Crowe United States 14 441 1.1× 237 0.7× 186 1.5× 101 0.8× 50 0.7× 20 658
Jacqueline Gillis United States 15 526 1.4× 222 0.7× 89 0.7× 320 2.5× 44 0.6× 22 935
Panyupa Pankhong United States 10 385 1.0× 243 0.8× 158 1.2× 150 1.2× 49 0.7× 22 717
Timothy Dudek United States 12 273 0.7× 214 0.7× 74 0.6× 103 0.8× 93 1.3× 16 556

Countries citing papers authored by Karen Herd

Since Specialization
Citations

This map shows the geographic impact of Karen Herd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Herd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Herd more than expected).

Fields of papers citing papers by Karen Herd

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Herd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Herd. The network helps show where Karen Herd may publish in the future.

Co-authorship network of co-authors of Karen Herd

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Herd. A scholar is included among the top collaborators of Karen Herd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Herd. Karen Herd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Herd, Karen, Michelle Nelson, Suresh Mahalingam, & Robert W. Tindle. (2010). Pulmonary infection of mice with human metapneumovirus induces local cytotoxic T-cell and immunoregulatory cytokine responses similar to those seen with human respiratory syncytial virus. Journal of General Virology. 91(5). 1302–1310. 25 indexed citations
2.
Herd, Karen, Michael D. Nissen, Peter Hopkins, Theo P. Sloots, & Robert W. Tindle. (2008). Major Histocompatibility Complex Class I Cytotoxic T Lymphocyte Immunity to Human Metapneumovirus (hMPV) in Individuals with Previous hMPV Infection and Respiratory Disease. The Journal of Infectious Diseases. 197(4). 584–592. 16 indexed citations
5.
Herd, Karen, Tracey J. Harvey, Alexander A. Khromykh, & Robert W. Tindle. (2004). Recombinant Kunjin virus replicon vaccines induce protective T-cell immunity against human papillomavirus 16 E7-expressing tumour. Virology. 319(2). 237–248. 31 indexed citations
6.
Doan, Tracy, Karen Herd, Ian A. Ramshaw, Scott Thomson, & Robert W. Tindle. (2004). A polytope DNA vaccine elicits multiple effector and memory CTL responses and protects against human papillomavirus 16 E7-expressing tumour. Cancer Immunology Immunotherapy. 54(2). 157–171. 19 indexed citations
7.
Street, Michael, Tracy Doan, Karen Herd, & Robert W. Tindle. (2002). Limitations of HLA‐transgenic mice in presentation of HLA‐restricted cytotoxic T‐cell epitopes from endogenously processed human papillomavirus type 16 E7 protein. Immunology. 106(4). 526–536. 25 indexed citations
8.
Tindle, Robert W., Karen Herd, Tracy Doan, et al.. (2001). Nonspecific Down-Regulation of CD8+T-Cell Responses in Mice Expressing Human Papillomavirus Type 16 E7 Oncoprotein from the Keratin-14 Promoter. Journal of Virology. 75(13). 5985–5997. 18 indexed citations
10.
Doan, Tracy, Karen Herd, Paul F. Lambert, et al.. (2000). Peripheral tolerance to human papillomavirus E7 oncoprotein occurs by cross-tolerization, is largely Th-2-independent, and is broken by dendritic cell immunization.. PubMed. 60(11). 2810–5. 36 indexed citations
11.
Frazer, Ian H., et al.. (1999). Safety and Immunogenicity of HPV16 E7/Algammulin. Journal of Ophthalmic Inflammation and Infection. 2(1). 91–104. 9 indexed citations
12.
Herd, Karen, et al.. (1999). T-Helper Epitopes Identified Within the E6 Transforming Protein of Cervical Cancer-Associated Human Papillomavirus Type 16. Viral Immunology. 12(4). 297–312. 9 indexed citations
13.
Street, Michael, Karen Herd, Tracy Doan, et al.. (1999). Differences in the effectiveness of delivery of B- and CTL-epitopes incorporated into the Hepatitis B core antigen (HBcAg) c/e1-region. Archives of Virology. 144(7). 1323–1343. 8 indexed citations
14.
Doan, Tracy, Michael Street, Germain J. P. Fernando, et al.. (1998). Mice Expressing the E7 Oncogene of HPV16 in Epithelium Show Central Tolerance, and Evidence of Peripheral Anergising Tolerance, to E7-Encoded Cytotoxic T-Lymphocyte Epitopes. Virology. 244(2). 352–364. 39 indexed citations
16.
Chatfield, Steven N., Robert W. Tindle, Karen Herd, et al.. (1996). Immunisation of mice using Salmonella typhimurium expressing human papillomavirus type 16 E7 epitopes inserted into hepatitis B virus core antigen. Vaccine. 14(6). 545–552. 59 indexed citations
19.
Tindle, Robert W., et al.. (1992). Humoral immune response to the E7 open reading frame protein of human papillomavirus genotype 16 in subjects with anogenital papillomavirus infection and controls. Queensland's institutional digital repository (The University of Queensland). 2. 223–228. 1 indexed citations
20.
Barry, M. Anita, et al.. (1990). Prevalence of markers for hepatitis B and hepatitis D in a municipal house of correction.. American Journal of Public Health. 80(4). 471–473. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026